Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
General Introduction | Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. is a listed company controlled by Guangzhou Pharmaceutical Group Co., Ltd. (A-share 600332, H-share 00874), mainly engaged in: (1) research and development, manufacturing, and sales of traditional Chinese and Western medicine, chemical raw materials, natural drugs, biopharmaceuticals, and intermediate chemical raw materials; (2) Wholesale, retail, and import and export business of Western medicine, traditional Chinese medicine, and medical devices; (3) Research and development, production, and sales of major health products; And (4) investment in health industries such as medical services, health management, and health care and elderly care. |
Headquarter | Guangzhou |
Establish Date | 9/1/1997 |
Listed Code | 600332.SH |
Listed Date | 2/6/2001 |
Chairman | Li Chuyuan. |
CEO | Li Hong. |
Website | www.gybys.com.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial